In ₹ Crore except Per Share Latest Annual	MEDICO FY26	MEDICAMEQ FY26	HALEOSLABS FY26	AAREYDRUGS FY26	Peer Average
Valuation — at last close
P/E	◆ 12.16×	35.21×	25.33×	77.73×	46.09× -74%
P/B	2.11×	◆ 1.25×	2.05×	2.04×	1.78× +19%
EV/EBITDA	◆ 10.26×	18.31×	12.56×	49.64×	26.84× -62%
Market Cap	₹160 Cr	₹345 Cr	₹439 Cr	₹307 Cr	₹364 Cr -56%
Growth
Revenue CAGR 3Y	13.69%	11.97%	1.89%	◆ 96.26%	36.71% -63%
Revenue CAGR 5Y	—	—	4.68%	—	4.68%
Net Income CAGR 3Y	21.89%	-12.71%	16.09%	◆ 100.20%	34.53% -37%
Revenue YoY (latest Q)	◆ 81.43%	11.27%	-11.59%	-56.34%	-18.89% +531%
Net Income YoY (latest Q)	◆ 38.49%	15.35%	-58.00%	-25.36%	-22.67% +270%
Profitability
EBITDA Margin	8.25%	9.90%	◆ 13.38%	1.52%	8.27% 0%
Net Income Margin	◆ 6.35%	4.95%	5.33%	0.84%	3.71% +71%
Return on Common Equity	◆ 19.04%	3.95%	8.44%	2.75%	5.05% +277%
Return on Capital Employed	◆ 20.13%	4.92%	10.70%	2.94%	6.19% +225%
Return on Assets	◆ 9.61%	2.93%	4.22%	1.48%	2.88% +234%
Credit & Quality
Total Debt/Equity	0.25×	◆ 0.17×	0.47×	0.33×	0.32× -23%
Interest Coverage	◆ 7.71×	3.54×	4.53×	0.86×	2.98× +159%
Scale — latest FY
Revenue / Total Income	₹206 Cr	₹198 Cr	₹334 Cr	₹472 Cr	₹335 Cr -38%
Net Income	₹13.1 Cr	₹9.8 Cr	₹17.8 Cr	₹4 Cr	₹10.5 Cr +25%
Total Assets	₹153 Cr	₹372 Cr	₹454 Cr	₹297 Cr	₹375 Cr -59%
EPS	₹1.58	₹7.22	₹57.26	₹1.39	₹21.96 -93%
Book Value per Share	₹9.09	₹203.17	₹706.34	₹52.86	₹320.79 -97%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.